Aadi Bioscience, Inc. (AADI) Financials

AADI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 132.4 million 27.2 million
2023-09-30 139.7 million 21.5 million
2023-06-30 151.2 million 19.8 million
2023-03-31 170.7 million 24.7 million

AADI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -10.5 million 3.1 million
2023-09-30 -13.0 million 3.0 million
2023-06-30 -17.4 million 3.1 million
2023-03-31 -22.7 million 2.7 million

AADI Net Income

No data available :(

AADI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 108.8 million - 1.3 million
2023-09-30 119.3 million - 1.4 million
2023-06-30 134.9 million - 1.5 million
2023-03-31 151.2 million - 1.6 million

AADI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 27.0 million
2023-09-30 26.9 million
2023-06-30 26.9 million
2023-03-31 26.9 million

AADI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 816000 12.8 million 10.3 million -
2023-09-30 1.1 million 11.9 million 11.2 million -
2023-06-30 689000 13.3 million 11.8 million -
2023-03-31 1.4 million 11.0 million 11.2 million -

AADI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 6.3 million 927000
2023-09-30 6.0 million 697000
2023-06-30 6.2 million 656000
2023-03-31 5.9 million 529000

AADI

Price: $2.12

52 week price:
1.55
8.65

Earnings Per Share: -2.44 USD

P/E Ratio: -0.82

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 52100

Market Capitalization: 46.7 million

Links: